亚洲欧美不卡高清在线观看,伊人久久大香线蕉午夜av,亚洲综合色区在线观看,中文在线中文a,真正免费的毛片

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Singapore receives its first batch of Pfizer’s Paxlovid pill for COVID-19 treatment

FirstWordPharmaFebruary 14, 2022

Tag: singapore , Pfizer , Paxlovid

Singapore has received its first batch of Pfizer's oral COVID-19 treatment Paxlovid, after authorities last week said they had approved the tablet for COVID-19 in adults at risk for severe disease, reported CNA.

"This is the first oral antiviral medicine approved for treatment of COVID-19 infection in Singapore," noted said health minister Ong Ye Kung.

Paxlovid cut the risk of COVID-19-related hospitalisations or death by 88.9% when given within three days of symptom onset, according to a Health Sciences Authority (HSA) review of clinical data based on an ongoing Pfizer study.

Previous:Celartics Biopharma announces a new generation mRNA vaccine against COVID-19

Next:EdiGene and Neukio enter collaboration to develop next-generation immune cell therapies

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service